Organon CEO Kevin Ali to resign after probe into wholesaler sales practices
27/10/2025 11:40
Oct 27 (Reuters) - Organon OGN.N said on Monday CEO Kevin Ali will resign from his role and be replaced by Joseph Morrissey on an interim basis, after an internal investigation into wholesaler sales practices for its Nexplanon contraceptive implant. (Reporting by Puyaan Singh in Bengaluru; Editing by Devika Syamnath) ((Puyaan.Singh@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary